Atlassian (TEAM) looks to continue its streak of outperforming consensus estimates in fiscal 2025 when it reports its second ...
TD Cowen analyst Bryan Bergin updated his outlook on Adyen NV (AS:ADYEN:NA) (OTC: ADYYF), increasing the price target to EUR1 ...
In a report released today, Gautam Khanna from TD Cowen maintained a Hold rating on Hexcel (HXL – Research Report), with a price target of ...
On Friday, TD Cowen analyst Andrew Kligerman upgraded shares of Arthur J. Gallagher & Co. (NYSE:AJG) to Buy from Hold, setting a new price target of $377.00, up from $295.00. The upgrade follows ...
In a report released on January 6, Helane Becker from TD Cowen maintained a Hold rating ... Becker is a 5-star analyst with an average return of 14.4% and a 65.33% success rate.
Oceaneering International (NYSE:OII – Get Free Report) had its target price raised by TD Cowen from $26.00 to $27.00 in a note issued to investors on Wednesday,Benzinga reports. The brokerage pr ...
TD Cowen analyst Joshua Jennings initiated coverage of Anteris Technologies (AVR) with a Buy rating and $15 price target Anteris has developed DurAVR, a first-in-class biomimetic transcatheter ...
On Monday, TD Cowen analyst Jared Levine adjusted the stock price target for Paycom Software (ETR:SOWGn) (NYSE:NYSE:PAYC), a leading provider of comprehensive, cloud-based human capital management ...
On Monday, TD Cowen's analysts increased their price target on United Continental (NASDAQ:UAL) shares, moving the goal from $125.00 to $142.00 while maintaining a Buy rating. According to ...
Insulet (NASDAQ:PODD – Get Free Report) had its target price increased by investment analysts at TD Cowen from $264.00 to $324.00 in a research note issued to investors on Friday,Benzinga reports.
This analyst has an accuracy rate of 61%. TD Cowen analyst Helane Becker maintained a Buy rating and raised the price target from $59 to $75 on Nov. 12. This analyst has an accuracy rate of 65%.
Investing.com-- TD Cowen analysts have increased their price target for Butterfly Network, Inc (NYSE:BFLY), citing robust momentum in the global rollout of its iQ3 handheld ultrasound device.